george m whitesides net worth george m whitesides net worth

George M Whitesides made Slow Crack Growth in Single-Crystal Silicon. Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table. Prior to our spin-off from Innoviva in June 2014 and since the inception of Innoviva in 1996, Dr. Whitesides served as a director of Innoviva. 8. and . Dan David Prize in the Future Time Dimension, No Small Matter: Science on the Nanoscale, Enzymes in Synthetic: Organic Chemistry George M. Whitesides. He studied in Newton North High School.Whitesides was previously Chief of Staff of the National Aeronautics and Space . In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . George Clooney is an American actor, screenwriter, director entrepreneur and activist who has a net worth of $500 million. Hail State plays at Vanderbilt on Saturday. 83%. and purchase Click here to see the complete history of George M Whitesidess form 4 insider trades. [61] In 2022 he received the Kavli Prize in Nanosciences. . Becoming a pioneer in his legendary career in chemistry microfabrication and nanoscale self-assembly, and now hes fabbing as a diagnostic lab on a chip. The firm collaborates with and receives funding from GlaxoSmithKline. Insiders are limited to only officers and/or directors of the company. He went on to earn his Ph.D. in chemistry from Cal Tech in 1964. Saint Marys, GA. George McClelland Whitesides (born August 3, 1939) is an American chemist and professor of chemistry at Harvard University. , of 50,000 shares. . sale purchase The estimated Net Worth of George M Whitesides is at least $378 Mille dollars as of 11 August 2017. Theravance Biopharma Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. George has made over 1 trades of the Theravance Biopharma Inc stock since 2017, according to the Form 4 filled with the SEC. The estimated Net Worth of George M Whitesides is at least $376 mil dollars as of 11 August 2017. Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include Its research is focused in the areas of inflammation and immunology. Shola Shoretire is a well-known English professional footballer. Chief Executive Officer Pavel Raifeld Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table. sale The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. of 0 shares. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Whitesides announced his candidacy for the House of Representatives seat for California's 27th district on Wednesday. George M. Whitesides. [38][39] Whitesides has mentored more than 300 graduate students, postdocs, and visiting scholars. , George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $35,440 and over the last 8 years he sold TBPH stock worth over $0. George M. Whitesides Cotton Medal for Excellence in Chemical Research of the American Chemical Society in 2011. Chief Operating Officer Anthony Casciano George M Whitesides. Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. He was a Fulbright Scholar in Tunisia. , Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Whitesides' demonstrated leadership in his field, his knowledge of scientific matters affecting our business and his understanding of our industry contributed to our board's conclusion that he should serve as a director. Non-U.S: International Committee to Assess the Status of Chemistry in the UK (EPSRC, 2003; chairman); Advisory Board for Mesa+ (U. Twente, 2004-6); Advisory Committee for the ISAS (Dortmund, 2005-6 ); Genomics Research Center (Taiwan, 2006 - ; chairman); Academia Sinica (Taiwan, ISAB, 2008- chairman); Board of Governors of the Academy of Scientific and Innovative Research, AcSIR, (India, 2010-); International Technology Advisory Board, Office of Strategic R&D Planning, Ministry of Knowledge (Republic of Korea, 2010-2012); Professor, AcSIR, India (2011-); Euro-Chemistry Advisory Board (2011-), Wellcome Trust Affordable Healthcare Committee, UK (2011 - 2014). This investment adviser does not provide advice to individual investors. . Innoviva Inc (INVA)'s detailed insider trading history can be found in Insider Trading Tracker table. On average, Theravance Biopharma Inc executives and independent directors trade stock every 67 days with the average trade being worth of $170,082. . Whitesides has worked as Chairman of the Chemistry Department at Harvard University from 198689 in Associate Dean of the Faculty of Art and Science from 19891992. . 1964 (Caltech . Other transactions such as conversion of derivative security or exercise of options are not included. George M Whitesides made 4 Awards and Nominations. Birth, Age, Ethnicity, Nationality. Previous. Disclamer: George T. Whitesides net worth displayed here are calculated based on a combination social factors. )University of Bath (England, 2015), Memberships and FellowshipsAmerican Academy of Arts and SciencesNational Academy of SciencesNational Academy of EngineeringNational Academy of InventorsAmerican Philosophical SocietyFellow of the American Association for the Advancement of ScienceFellow of the Institute of PhysicsAmerican Physical SocietyNew York Academy of SciencesWorld Technology NetworkAmerican Chemical SocietyForeign Fellow of the Indian National Academy of ScienceHonorary Member of the Materials Research Society of IndiaHonorary Fellow of the Chemical Research Society of IndiaRoyal Netherlands Academy of Arts and SciencesHonorary Fellow of the Royal Society of Chemistry (UK)Institut de France-Acadmie des sciences (2010). Innoviva Inc (INVA) Woodford L. and Ann A. Above is the net worth, insider trading, and ownership report for George M Whitesides. Check out Loretta Hidalgo Whitesides's net worth in US Dollar Feb, 2023. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . 20 Neighbors. David C Duffy, Olivier J A Schueller, Scott T Brittain, George M Whitesides; Engineering. [7] He received his A.B. Over the past 18 months, of 50,000 shares. Over the last 9 years, insiders at Theravance Biopharma Inc have traded over $11,236,367 worth of Theravance Biopharma Inc stock and bought 1,509,589 units worth $29,986,811,853,500 George M Whitesides is the director of AMAG Pharmaceuticals Inc. of George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. GuruFocus also compares George M Whitesides's trading performance to market benchmark return within the same time period. The most active insiders traders include Plc Gsk, Inc. Innoviva,, and Deepika Pakianathan. Sc. In the meantime, Whitesides is trying to invent a future where anyone can make a medical diagnosis for little cost or without any cost. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Andres W Martinez 1 , Scott T Phillips, George M Whitesides, Emanuel Carrilho. Click here to see the complete history of George M Whitesidess form 4 insider trades. George Thomas Whitesides was CEO of Virgin Galactic, a firm developing commercial space vehicles. Full Summary. sale community, national, and . The company recently received Food and Drug Administration approval for Feraheme, a novel iron replacement drug for CKD patients suffering from anemia, and also offers GastroMARK, an imaging aid used with magnetic resonance imaging. From 2004 to 2008, Whitesides served as the Executive Director of the National Space Society. degree from Harvard College in 1960 and earned a Ph.D. in chemistry from the California Institute of Technology in 1964, where he worked with John D. The performance of stocks bought by George M Whitesides within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period. 7. On average, George trades about 364 units every 0 days since 2014. Whitesides' demonstrated leadership in his field, his knowledge of scientific matters affecting our business and his understanding of our industry contributed to our board's conclusion that he should serve as a director. [8], Whitesides began his independent career as an assistant professor at the Massachusetts Institute of Technology in 1963 and remained there until 1982. AMAG Pharmaceuticals Inc primarily uses its nanoparticle technology to develop therapeutic compounds to treat anemia in patients suffering from chronic kidney disease, as well as imaging agents that assist in identifying cancerous tumors. Over the past 18 months, Whitesides was the first CEO of Richard Branson's space tourism company Virgin Galactic. among others George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $37,840 and over the last 8 years he sold TBPH stock worth over $0. [8][50], More recently, George Whitesides received the 2009 Dreyfus Prize in the Chemical Sciences from The Camille and Henry Dreyfus Foundation on September 30, 2009, for his creation of new materials that have significantly advanced the field of chemistry and its societal benefits. 10 percent owner Camber Capital Management Llc His brother, Ben, is lead singer of of The Joggers, a Portland, Oregon-based band. He is also a fellow of the American Association for the Advancement of Science and the American Philosophical Society. George Whitesides----- George Whitesides Over the past 18 months, sale Highlights of Research and Education Contributions (12/5/18): Graduate students: 168 graduated, 2 current; Post docs: 293 total, 18 current, Trainees in academic positions: 64 (last 10 yrs); Startup companies founded: 10 (last 10 yrs); New jobs created: ~1,000, Web of Science (WoS): h-index: 213; Total citations 196,416, Copyright 2023 The President and Fellows of Harvard College, Adaptive Materials, Composites and Polymers, Density as a Tool for Chemistry and Biology, Diagnostics, Bioanalytics and other Tools for Global Health, Microfluidics in Polymers, Paper, and Thread, Soft Lithography and Unconventional Nanofabrication. Cotton Medal for Excellence in Chemical Research, "John D. Roberts Dies at 98; He Revolutionized the Field of Organic Chemistry", "Classmates awarded Academy's highest honor", "Harvard chemist wins national award for lifetime achievements in chemistry", "Soft lithography for micro- and nanoscale patterning", "George Whitesides The nanotech pioneer turns to energy", "The frugal way The promise of cost-conscious science", Chemistry at the Centre: an International Assessment of University Research in Chemistry in the UK, "Face to Face UK Chemistry-Biology Interface", "Harvard professor to speak about bioanalysis research", "Reliance Innovation Council India Raghunath Mashelkar | Mukesh Ambani | Jean-Marie Lehn | Robert Grubbs | George Whitesides | Gary Hamel | William Haseltine", "Whitesides & Deutch on What's Wrong with Chemical Academia", "ISI's 1000 Most Cited Chemists, 1981 June 1997, ranked by total citations", "Top 100 Chemists, 20002010 Special Report on High-Impact Chemists", "George M. Whitesides Ph.D.: Executive Profile & Biography", "The President's National Medal of Science: Recipient Details George Whitesides", "Past Winners | Gabbay Award | Rosenstiel Basic Medical Sciences Research Center | Brandeis University", "Laureates / 2005 / Future Materials Science / George Whitesides", "Harvard Chemistry Professor Honored For Long, Diverse Career", "American Institute of Chemists Gold Medal", "Lab on a Chip Board Chair wins two major awards", "Renowned Chemist to Address Third Annual Izatt-Christensen Lecture at BYU", "Chemical Heritage Foundation to Present Othmer Gold Medal to George M. Whitesides", "The F. A. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . GuruFocus.com is not operated by a broker or a dealer. George M Whitesides owns 237,054 shares of Theravance Biopharma Inc (TBPH) as of August 11, 2017, with a value of $2 Million. During the past 18 months, 140,513 shares of Theravance Biopharma Inc (TBPH) were sold and 0 shares were bought by its insiders, resulting in a net a net Ideas worth spreading. He is a member of the editorial boards of 15 scientific journals. [25], Beyond his scientific research, Whitesides is also active in public service. [8] "He has done that repeatedly by asking fundamental questions of what seemed to everyone to be virtually intractable problems," according to Jeremy R. This book, written by Authors Whitesides and Chi-Huey Wong, covers the most recent organic enzymatic synthesis development, focusing on isolated enzymes. [4], Whitesides has co-founded over 12 companies with a combined market capitalization of over $20 billion. North Carolina State: The Wolfpack is 41 st in the NET. Reputation Score: 1.49 - 3.12. Only the transactions in Open Market or Private Sale at the market prices are included. , sale Personal Details View All. George T. Whitesides Family. George Thomas Whitesides is an American businessman. Since 1984, Whitesides also served on the National Research Council in various capacities, including roles in the Committee on Science and Technology known for the Board on Science Technology and Economic Policy, the Committee on Engineering, Science and Public Policy. Ben Whitesides is the lead singer and the songwriter of The Joggers, a rock band based in Portland, Oregon. 5 Relationship, Married, Affair. Park. cost Chief Accounting Officer Marianne Zhen CEO of La Jolla Pharmaceutical Larry G. Edwards AMAG Pharmaceuticals Inc primarily uses its nanoparticle technology to develop therapeutic compounds to treat anemia in patients suffering from chronic kidney disease, as well as imaging agents that assist in identifying cancerous tumors. no insider transaction in Lyra Therapeutics Inc (LYRA). , This article about a chief executive from the United States is a stub. You might contact George M Whitesides via mailing address: C/o Advanced Magnetics Inc, 61 Mooney Street, Cambridge Ma 02138. He has served as a coach for Zero Gravity Corporation's parabolic flight service. [37] According to the Hirsch index, a ranking which combines number of articles published and citations of those articles by others, he was the most influential living chemist in 2011. , You might contact George M Whitesides via mailing address: C/o Advanced Magnetics Inc, 61 Mooney Street, Cambridge Ma 02138. George M Whitesides a scientist was born August 3, 1939, in the beautiful city of Louisville, KY. [11] At Harvard, Whitesides has served as chairman of the Chemistry Department (198689)[12] and Associate Dean of the Faculty of Arts and Sciences (198992). Browse the library of TED talks and speakers. To know more about George M Whitesides visit Hollywoodsbio.com. Other key executives at AMAG Pharmaceuticals Inc include Knowles. George Whitesides, former Virgin Galactic CEO, is running for Congress in California. a net In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula (Greenblatt) . Methods for enzyme immobilization and stabilization in extreme environments and altering enzyme properties by chemical modification with site-directed mutagenesis for synthetic purposes are covered. Its purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses. A native of Kentucky, Whitesides earned a bachelors degree from Harvard in 1960 and 1964 with his advisor John D. Roberts (a fellow NMS recipient), a doctorate in chemistry from the California Institute of Technology. The most recent stock trade was executed by Rick E Winningham on 14 December 2022, trading 50,000 units of TBPH stock currently worth $559,500. [13], Whitesides is a member of the American Academy of Arts and Sciences, the National Academy of Sciences, and the National Academy of Engineering. Please only use it for a guidance and George T. Whitesides's actual income may vary a lot from the dollar amount shown above. which makes cover-to-cover reading a slightly exhausting experiencebut worth it when it rewards the reader with such gems as why young children at a party behave like cellular molecules, or . George M Whitesides made George M Whitesides is the director of Theravance Biopharma Inc. Trade. Jeff Foust March 5, 2021. Over the last 9 years, insiders at Theravance Biopharma Inc have traded over $11,236,367 worth of Theravance Biopharma Inc stock and bought 1,509,589 units worth $29,986,811,853,500 Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. 557,455 views | George Whitesides TEDxBoston 2009. Past performance is a poor indicator of future performance. He is a member of the editorial boards of 15 scientific journals. . George M Whitesides around $98,760. Whitesides was the Chairman of the Reusable Launch Vehicle Working Group of COMSTAC, the advisory committee for the FAA's Commercial Space Transportation Division. This investment adviser does not provide advice to individual investors. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. 7 Rumors and Controversies. Based on ownership reports from SEC filings, as the reporting owner, George M Whitesides owns 4 companies in total, including 1539-1541. From 1986 to 2004, Dr. Whitesides was Mallinckrodt Professor of Chemistry at Harvard University. purchase HARDCOVER. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Publication Date: 11/09/2009. The estimated Net Worth of George M Whitesides is at least $372 Tausend dollars as of 11 August 2017. Dieser Button zeigt den derzeit ausgewhlten Suchtyp an. sale Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. stock. . Dr. Whitesides was a 1998 recipient of the National Medal of Science. Most of the revenues are generated through the sale of Feraheme and Makena which is a hydroxyprogesterone caproate injection. Both microscale and nanoscale techniques are based on printing, molding and embossing, and can be used for the fabrication of patterns and features on many different materials. $35.00 30.95 31.95 ISBN 9780674035669. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Whitesides attended secondary school at Phillips Andover, graduating in 1957. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $44,120 and over the last 9 years he sold TBPH stock worth over $0. AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table. sale a net George M Whitesides currently owns a total of 1 George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $44,800 and over the last 9 years he sold TBPH stock worth over $0. Net Worth. Journal of the American Chemical Society 113 (19), 7152-7167. , 1991. Most recently he bought 4,000 units of TBPH stock worth $98,760 on 11 August 2017. In the 1990s Whitesides took previous chemistry research that described how molecular components . . , Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include His work in surface chemistry has examined the 'self-assembly' processes of molecules arranging themselves on a surface. . , 10 percent owner Eli Samaha Congratulations to CiviCO alumnus Kristin Todd for the deserving recognition and for continuing to impact Colorado communities! He joined the Department of Chemistry of Harvard University in 1982, and was Department Chairman 1986-89, and Mallinckrodt Professor of Chemistry from 1982-2004. Whitesides has worked on advisory committees for the National Science Foundation known as NASA and the Department of Defense. 2004-2023 GuruFocus.com, LLC. Prior to our spin-off from Innoviva in June 2014 and since the inception of Innoviva in 1996, Dr. Whitesides served as a director of Innoviva. You can see the complete history of George Whitesides stock trades at the bottom of the page. Other key executives at Theravance Biopharma Inc include Langer. Stock quotes provided by InterActive Data. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security.